Literature DB >> 10595734

Screening for nicotine dependence among smoking-related cancer patients.

I Mikami1, T Akechi, A Kugaya, T Okuyama, T Nakano, H Okamura, S Yamawaki, Y Uchitomi.   

Abstract

To identify lung and head-and-neck cancer patients who will have difficulty stopping smoking it is necessary to measure the severity of their nicotine dependence. In this study, we compiled a Japanese version of the Fagerstrom test for nicotine dependence (FTND) and examined its reliability and validity. One hundred and fifty-one cancer patients participated in this study and took our Japanese version of the FTND. Socio-demographic and medical data and information about smoking habits were obtained from a semi-structured interview, and the patients' nicotine dependence was evaluated according to the Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed., Rev. (DSM-III-R). The mean FTND scores+/-SD of the group with nicotine dependence and the group without nicotine dependence were 6.85+/-2.00 and 3.70+/-2.13 respectively, and the difference was significant (P<0.001, Mann-Whitney's U-test). The test-retest correlation was 0.75. Cronbach's alpha of the FTND was 0.66. The FTND score correlated significantly with the number of satisfied criteria of nicotine dependence (r=0.70; P<0.001, Pearson's correlation). By using a receiver-operating-characteristic curve, we determined a score of 5/6 as a suitable cut-off point for nicotine dependence; this point gave high sensitivity and specificity (0.75 and 0.80, respectively). These results suggest that our Japanese version of FTND is a reliable and valid measure of nicotine dependence in patients with smoking-related cancers.

Entities:  

Mesh:

Year:  1999        PMID: 10595734      PMCID: PMC5926006          DOI: 10.1111/j.1349-7006.1999.tb00679.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  14 in total

Review 1.  Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.

Authors:  N L Benowitz
Journal:  N Engl J Med       Date:  1988-11-17       Impact factor: 91.245

2.  Failure to support the validity of the Fagerstrom Tolerance Questionnaire as a measure of physiological tolerance to nicotine.

Authors:  T W Lombardo; J R Hughes; J D Fross
Journal:  Addict Behav       Date:  1988       Impact factor: 3.913

3.  Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence.

Authors:  C S Pomerleau; S M Carton; M L Lutzke; K A Flessland; O F Pomerleau
Journal:  Addict Behav       Date:  1994 Jan-Feb       Impact factor: 3.913

4.  Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

Authors:  K O Fagerström
Journal:  Addict Behav       Date:  1978       Impact factor: 3.913

5.  A comparison of psychological and pharmacological treatment in smoking cessation.

Authors:  K O Fagerström
Journal:  J Behav Med       Date:  1982-09

6.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

7.  Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol.

Authors:  G L Day; W J Blot; R E Shore; J K McLaughlin; D F Austin; R S Greenberg; J M Liff; S Preston-Martin; S Sarkar; J B Schoenberg
Journal:  J Natl Cancer Inst       Date:  1994-01-19       Impact factor: 13.506

8.  Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers.

Authors:  G E Richardson; M A Tucker; D J Venzon; R I Linnoila; R Phelps; J C Phares; M Edison; D C Ihde; B E Johnson
Journal:  Ann Intern Med       Date:  1993-09-01       Impact factor: 25.391

9.  Effects of a nicotine-enriched cigarette on nicotine titration, daily cigarette consumption, and levels of carbon monoxide, cotinine, and nicotine.

Authors:  K O Fagerström
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Signs and symptoms of tobacco withdrawal.

Authors:  J R Hughes; D Hatsukami
Journal:  Arch Gen Psychiatry       Date:  1986-03
View more
  6 in total

1.  The day-to-day process of stopping or reducing smoking: a prospective study of self-changers.

Authors:  Erica N Peters; John R Hughes
Journal:  Nicotine Tob Res       Date:  2009-06-26       Impact factor: 4.244

2.  Nicotine dependence and smoking habits in patients with head and neck cancer.

Authors:  Adriana Ávila de Almeida; Celso Muller Bandeira; Antonio José Gonçalves; Alberto José Araújo
Journal:  J Bras Pneumol       Date:  2014 May-Jun       Impact factor: 2.624

3.  Tobacco dependence among people with mental illness: a facility-based cross sectional study from Southwest Ethiopia.

Authors:  Zemenay Molla; Lamesa Dube; Wolfgang Krahl; Matiwos Soboka
Journal:  BMC Res Notes       Date:  2017-07-17

4.  Prevalence of tobacco dependence and associated factors among patients with schizophrenia attending their treatments at southwest Ethiopia; hospital-based cross-sectional study.

Authors:  Defaru Desalegn; Zakir Abdu; Mohammedamin Hajure
Journal:  PLoS One       Date:  2021-12-15       Impact factor: 3.240

5.  Substance use disorders and adherence to antituberculosis medications in Southwest Ethiopia: a prospective cohort study.

Authors:  Matiwos Soboka; Markos Tesfaye; Kristina Adorjan; Wolfgang Krahl; Elias Tesfaye; Yimenu Yitayih; Ralf Strobl; Eva Grill
Journal:  BMJ Open       Date:  2021-07-05       Impact factor: 2.692

6.  Prevalence and analysis of tobacco use disorder in patients diagnosed with lung cancer.

Authors:  Soo-Hyun Paik; Chang Dong Yeo; Jo-Eun Jeong; Ju Sang Kim; Sang Haak Lee; Seung Joon Kim; Dai-Jin Kim
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.